nutrients

Editorial
Dietary Intake and Type 2 Diabetes
Omorogieva Ojo
School of Health Sciences, University of Greenwich, London SE9 2UG, UK; o.ojo@greenwich.ac.uk;
Tel.: +44-020-8331-8626; Fax: +44-020-8331-8060




Received: 4 September 2019; Accepted: 6 September 2019; Published: 11 September 2019


Abstract: This editorial aims to examine the risk factors associated with type 2 diabetes and to discuss
the evidence relating to dietary strategies for managing people with this condition. It is clear from the
evidence presented that a range of dietary interventions can provide useful approaches for managing
people with type 2 diabetes, including the regulation of blood glucose and lipid parameters, and for
reducing the risks of acute and chronic diabetic complications.

Keywords: type 2 diabetes; dietary intake; glycaemic control; dietary management approaches;
micronutrients; macronutrients; nutrition; chronic conditions; lipid parameters

Diabetes is a metabolic condition that is characterized by chronic hyperglycemia and results from
an interplay of genetic and environmental factors [1–4]. Its prevalence is on the increase in the UK
and worldwide, partly due to changes in lifestyle that predispose individuals to obesity and being
overweight [1,3–6]. It is estimated that about 90% of adults currently diagnosed with diabetes have
type 2 diabetes and, based on a World Health Organisation (WHO) report, about 422 million adults
were living with diabetes in 2014 compared with 108 million in 1980 and this condition caused about
1.5 million deaths in 2012 [7,8]. The United States of America has about 30.3 million adults living
with diabetes, and 1.5 million estimated new diabetes cases are diagnosed every year, representing an
increasing prevalence of this condition [9]. Diabetes presents a major public health challenge despite the
developments in technology and the pharmaceutical industry [9]. These problems may be in the form
of acute or chronic complications and changes in body composition can be profound. In this regard,
Almusaylim et al. [10] conducted a cross-sectional and longitudinal study to evaluate the associations
between variations in glycaemic status and changes in total body, trunk, appendicular fat mass,
and lean mass in men. The longitudinal analyses demonstrated that changes in total body, fat mass and
lean mass, and appendicular lean mass differed among glycaemic groups [10]. In addition, glucose
dysregulation was found to be related to adverse changes in total body and appendicular lean mass.
Therefore, in order to attenuate the problems of diabetes, management strategies usually include
lifestyle changes such as increased physical activities and dietary interventions. Studies that evaluate
the role of nutrition in the management of type 2 diabetes often involve human and animal models
as these approaches enable us to have a broader and more in-depth understanding of the condition.
Sometimes, diabetes may co-exist with other conditions such as stroke and these may present unique
challenges in relation to nutritional interventions.
The current editorial aims to evaluate the risk factors associated with type 2 diabetes and the role
of diet in the management of people with the condition. It involves evidence drawn from human and
animal studies.
In one of the studies, Muñoz-Garach et al. [11] examined the role of vitamin D status, calcium
intake, and the risk of developing type 2 diabetes. According to the authors, the role of vitamin D in
glucose homeostasis appears to be its association with insulin secretion, insulin resistance, and systemic
inflammation and this is one of its important non-skeletal functions [11]. In addition, there seems to be
a link between the consumption of dairy products and a lower risk of type 2 diabetes and this has been

Nutrients 2019, 11, 2177; doi:10.3390/nu11092177 www.mdpi.com/journal/nutrients

demonstrated in many observational studies although the mechanism and the role of calcium intake in
the risk of developing this condition have not been well established [11]. Therefore, a randomized
controlled trial on the role of vitamin D and calcium in the development of type 2 diabetes will further
elucidate our understanding of the mechanisms of action of these micronutrients [11]. In a related
study, Contreras-Manzano et al. [12] explored cardiovascular risk factors and their association with
vitamin D deficiency based on a nationally representative sample of 3260 young Mexican women.
The authors found that the prevalence of vitamin D deficiency among the women aged 20 to 49 years
old was a public health problem and that obesity, type 2 diabetes, and high total cholesterol were found
to be associated with vitamin D deficiency.
On the other hand, Fernández-Cao et al. [13] conducted a systematic review and meta-analysis in
order to evaluate the effect of dietary, supplementary, and total zinc intake and status on the risk of
developing type 2 diabetes. This was based on the understanding that zinc may have a protective role
against type 2 diabetes [13]. The results showed that a moderately high dietary zinc intake based on
the ‘Dietary Reference Intake’ may reduce the risk of type 2 diabetes by 13% and up to 41% in rural
settings [13]. In contrast, elevated serum/plasma zinc concentration was found to be associated with an
increased risk of type 2 diabetes in the general population, although no relationship was established
between total or supplementary zinc intake and type 2 diabetes [13]. Brandão-Lima et al. [14] also
explored the relationship between the dietary intake of zinc, potassium, calcium, and magnesium
and glycaemic control in patients with diabetes. The authors used multiple linear regression and
binary logistic regression analysis to evaluate the effects of individual and combination intake of these
micronutrients on glycated hemoglobin (HbA1c) and found a high likelihood of inadequate intake
of the micronutrients. In addition, it was noted that the group with a lower micronutrient intake
demonstrated higher % HbA1c (p = 0.006) and triglyceride (p = 0.010) levels [14].
Apart from evaluating the association between micronutrients and the risk of type 2 diabetes,
the role of macronutrients and other metabolites in the development of this condition have been studied
extensively. Song et al. [15] sought to examine whether dietary patterns that explain the variation of
the triglyceride (TG) to high-density lipoprotein cholesterol (HDL-C) ratio were associated with the
incidence of type 2 diabetes in Korean men and women. The authors found evidence that suggests
that dietary patterns associated with low levels of TG/HDL-C ratio may have the potential to reduce
the risk of type 2 diabetes.
Based on the above, it is essential that dietary management approaches that are tailored to meet
the needs of people with type 2 diabetes reflect these elements that are aimed at reducing the risk of
acute and chronic complications. In this regard, Hallberg et al. [9] noted in their narrative review that
there is evidence that suggests the possible reversal of this condition through interventions and these
have been incorporated into guidelines. These approaches may involve the use of bariatric surgery,
low-calorie diets, or carbohydrate restriction [9]. In particular, the American Diabetes Association and
the European Association for the Study of Diabetes have recommended a low carbohydrate diet and
support the use of short-term low-calorie diets for weight loss.
A low carbohydrate diet (LCD), replacing some staple foods with nuts such as tree nuts and
groundnuts, has been shown to reduce weight, improve blood glucose, and regulate blood lipid in
patients with type 2 diabetes [16]. However, the consumption of tree nuts is difficult to promote
in patients with diabetes because they are relatively more expensive compared to groundnuts [16].
It remains unclear whether peanuts and tree nuts, including almonds, in combination with LCD have
similar benefits in patients with type 2 diabetes. Therefore, Hou et al. [16] conducted a randomized
controlled trial to compare the effect of peanuts and almonds on the cardio-metabolic and inflammatory
parameters in patients with type 2 diabetes. This was a parallel design involving 32 patients with type
2 diabetes [16]. The patients consumed a LCD with part of the starchy staple food being replaced
with peanuts (peanut group) or almonds (almond group) and involved a follow-up period of three
months [16]. The findings showed that the fasting blood glucose (FBG) and postprandial 2-h blood
glucose (PPG) decreased in both the peanut and almond groups (p < 0.05) compared with the baseline,
Nutrients 2019, 11, 2177 3 of 6

and, following the intervention, there was no significant difference between the peanut group and
the almond group with respect to the FBG and PPG levels [16]. However, compared to the baseline
value, there was a decrease in the glycated hemoglobin level in the almond group (p < 0.05) and no
significant difference was found between the peanut and almond groups with respect to the HbA1c
level at the third month. The authors concluded that when incorporated into a LCD, almonds and
peanuts have a similar effect on improving fasting and postprandial blood glucose among patients
with type 2 diabetes.
In a separate study, Yamada et al. [17] conducted a systematic review of dietary approaches
for Japanese patients with diabetes. The main focus of the review was to elucidate the effect of
an energy-restricted and carbohydrate-restricted diet on the management of Japanese patients with
diabetes [17]. All the randomized controlled trials included in the review showed better glucose
management with the carbohydrate-restricted diet. It was found that carbohydrate-restricted diet,
not the energy-restricted diet, might have short term benefits for managing Japanese patients with
diabetes although the low number of studies included in the review was a limitation [17].
Burch et al. [18] also developed a protocol for a longitudinal study on evaluating how diet changes
with the diagnosis of diabetes. It has been observed that the quality of diets plays a significant
role in assisting people with type 2 diabetes to manage their condition and thus reduce the risk of
developing diabetes-related complications [18,19]. This is because diet quality is the extent to which
food intake complies with national or international dietary guidelines or a priori diet quality score and
it influences glycaemic control in people with type 2 diabetes and has a significant impact on the risk of
complications [18,20]. It often includes the macronutrient components of the diet. Thus, Telle-Hansen
et al. [21] summarized the research evidence on randomized controlled trials of the effect of dietary
polyunsaturated fatty acids (PUFAs) on glycaemic control in people with type 2 diabetes. This study
was based on the fact that replacing saturated fatty acids (SFAs) with PUFAs decreases blood cholesterol
levels and prevents cardiovascular diseases and that fat quality may also affect insulin sensitivity and
increase the risk of type 2 diabetes [21]. Evidence from prospective studies has also shown that a high
intake of SFAs can increase the risk of type 2 diabetes, while a high intake of PUFAs reduces the risk
of the condition [21]. Based on this review, while about half of the studies that examined the effect
of fish, fish oils, vegetable oils, or nuts found changes related to glycaemic control in people with
type 2 diabetes, the other half found no effects [21]. In addition, it remains unclear whether PUFAs
from marine or vegetable sources affect glycaemic regulation differently and this is a potential area for
future research [21].
What is clear, however, is that a low glycaemic index (GI) diet is more effective in controlling
glycated hemoglobin and fasting blood glucose than a high GI diet in patients with type 2 diabetes [22].
In a further systematic review and meta-analysis, Ojo et al. [23] sought to evaluate the effects of a low
GI diet on the cardio-metabolic and inflammatory parameters in patients with type 2 diabetes and in
women with gestational diabetes mellitus (GDM) and examine whether the effects are different in these
conditions. While 10 randomized controlled studies were included in the systematic review, only 9 were
selected for the meta-analysis [23]. The results of the meta-analysis found no significant differences
(p > 0.05) between the low GI and higher GI diets with respect to total cholesterol, high-density
lipoprotein (HDL), and low-density lipoprotein (LDL) cholesterol in patients with type 2 diabetes.
With respect to the triglyceride, it increased by a mean of 0.06 mmol/L (0.01, 0.11) in patients with type
2 diabetes on a high GI diet and the difference compared with the low GI diet group was significant
(p = 0.027) [23]. The results from the systematic review were not consistent in terms of the effect of a
low GI diet on the lipid profile in women with GDM [23]. Furthermore, the low GI diet significantly
decreased interleukin–6 (p = 0.001) in patients with type 2 diabetes compared to the high GI diet [23].
Nutritional approaches employed in managing patients with type 2 diabetes may also involve the
use of enteral nutrition, including oral nutritional supplements (ONS) [3]. The effectiveness of these
diabetes-specific formula (DSF) and standard formulas on glycaemic control and lipid profile in patients
with type 2 diabetes continues to generate interest. Based on this, Ojo et al. [1] used a systematic
Nutrients 2019, 11, 2177 4 of 6

review and meta-analysis of randomized controlled trials to evaluate the effect of diabetes-specific
enteral nutrition formula on cardiometabolic parameters in patients with type 2 diabetes. On the other
hand, Angarita Dávila et al. [3], conducted a randomized cross-over study to explore the effect of
oral diabetes-specific nutritional supplements with sucromalt and isomaltulose compared with the
standard formula (SF) on glycaemic index, entero-insular axis peptides, and subjective appetite in
patients with type 2 diabetes.
In the review by Ojo et al. [1], it was found that all the fourteen studies included in the systematic
review showed that DSF was effective in lowering blood glucose parameters in patients with type 2
diabetes compared with SF. The results of the meta-analysis confirmed the findings of the systematic
review with respect to the fasting blood glucose, which was significantly lower (p = 0.01) in the DSF
group compared to SF, and the glycated hemoglobin, which was significantly lower (p = 0.005) in the
DSF group compared to the SF group [1]. Based on the systematic review, the outcomes of the studies
selected to evaluate the effect of DSF on lipid profile were variable. The authors concluded that the
results provided evidence to suggest that DSF is effective in controlling fasting blood glucose and
glycated hemoglobin and in increasing HDL cholesterol, but has no significant effect on other lipid
parameters. They further noted that the presence of low glycaemic index (GI) carbohydrates, a lower
amount of carbohydrates and a higher amount protein, the presence of mono-unsaturated fatty acids,
and different amounts and types of fiber in the DSF compared with SF may be responsible for the
observed differences in cardiometabolic parameters in both groups [1].
Angarita Dávila et al. [3] also compared the postprandial effects of oral diabetes-specific nutritional
supplements with isomaltulose and sucromalt versus the standard formula (SF) on the glycaemic index
(GI), insulin, glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide 1 (GLP-1),
and subjective appetite in people with type 2 diabetes. The subjects were given a portion of supplements
containing 25 g of carbohydrates or reference food following overnight fasting [3]. The glycaemic index
values were low for oral diabetes-specific nutritional supplements and intermediate for SF (p < 0.001).
The area under the curve for insulin and GIP were lower (p < 0.02 and p < 0.02 respectively) after
oral diabetes-specific nutritional supplements and higher (p < 0.05) for GLP-1 when compared with
SF [3]. In addition, the subjective appetite area under the curve was greater (p < 0.05) after SF than oral
diabetes-specific nutritional supplements [3].
The management of type 2 diabetes may also include the administration of insulin. But questions
remain whether the dose of insulin before a meal should be based on glycemia or meal content [24].
Krzymien et al. [24] reviewed existing guidelines and scientific evidence on insulin dosage in people
with type 1 and type 2 diabetes and explored the effect of the meal composition such as carbohydrate,
protein and fat on postprandial glucose. The authors found that in most current guidelines aimed at
establishing prandial insulin doses in type 1 diabetes, only carbohydrates are counted, whereas in
type 2 diabetes the meal content is often not taken into consideration. Therefore, it was concluded
that prandial insulin doses in managing people with diabetes should take into account the pre-meal
glycemia, as well as the size and composition of the meals [24].
Apart from human studies, research based on the effects of different extracts on animal models
have been conducted in an attempt to further elucidate our understanding of their role in diabetes.
Tse et al. [25] assessed the glycemic lowering effect of an aqueous extract of Hedychium coronarium
leaves in diabetic rodents. The study involved streptozotocin-induced type 2 diabetes Wistar rats
and C57BKSdb/db mice. After treatment with Hedychium coronarium for 28 days, glucose tolerance
improved in both of the diabetic animal models. The Hedychium coronarium also significantly improved
the lipid profile in streptozotocin-induced type 2 diabetic rats [25]. On the other hand, Vlavcheski and
Tsiani [26] explored the reduction of free fatty acid-induced muscle insulin resistance by Rosemary
extract. It was found that Rosemary extract has the potential to counteract the palmitate-induced
muscle cell insulin resistance [26].
In another study, Huang et al. [27] examined the effects of Tempeh fermentation with Lactobacillus
plantarum and Rhizopus oligosporus on streptozotocin-induced type 2 diabetes rats. The results
Nutrients 2019, 11, 2177 5 of 6

demonstrated that the modulation of serum glucose and lipid levels by lactic acid bacteria occurs via
alterations in the internal microbiota, leading to the inhibition of cholesterol synthesis and promotion
of lipolysis [27]. Furthermore, it was suggested that Tempeh, might be a beneficial dietary supplement
for individuals with abnormal carbohydrate metabolism [27].
Yang et al. [28] also evaluated the combination of freeze-dried Aronia, red ginseng,
ultraviolet-irradiated shiitake mushroom, and nattokinase in order to examine its effects on insulin
resistance, insulin secretion, and the gut microbiome in a non-obese type 2 diabetic animal model.
It was concluded that the combination of freeze-dried Aronia, red ginseng, ultraviolet-irradiated
shiitake mushroom, and nattokinase improved glucose metabolism by potentiating insulin secretion
and reducing insulin resistance in insulin-deficient type 2 diabetic rats [28]. The improvement of
diabetic status ameliorated body composition changes and prevented changes in gut microbiome
composition [28].
Overall, this editorial has demonstrated that a range of dietary interventions can provide useful
approaches for managing people with type 2 diabetes including regulating blood glucose parameters
and lipid profiles and for reducing the risks of acute and chronic diabetic complications.

Funding: This research received no external funding.

References
1. Ojo, O.; Weldon, S.M.; Thompson, T.; Crockett, R.; Wang, X.-H. The Effect of Diabetes-Specific Enteral
Nutrition Formula on Cardiometabolic Parameters in Patients with Type 2 Diabetes: A Systematic Review
and Meta–Analysis of Randomised Controlled Trials. Nutrients 2019, 11, 1905. [CrossRef] [PubMed]
2. DeFronzo, R.A.; Ratner, R.E.; Han, J.; Kim, D.D.; Fineman, M.S.; Baron, A.D. Effects of exenatide (exendin-4)
on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes. Diabetes
Care 2005, 28, 1092–1100. [CrossRef] [PubMed]
3. Angarita Dávila, L.; Bermúdez, V.; Aparicio, D.; Céspedes, V.; Escobar, M.C.; Durán-Agüero, S.; Cisternas, S.;
de Assis Costa, J.; Rojas-Gómez, D.; Reyna, N.; et al. Effect of Oral Nutritional Supplements with Sucromalt
and Isomaltulose versus Standard Formula on Glycaemic Index, Entero-Insular Axis Peptides and Subjective
Appetite in Patients with Type 2 Diabetes: A Randomised Cross-Over Study. Nutrients 2019, 11, 1477.
[CrossRef] [PubMed]
4. Rosen, E.D.; Kaestner, K.H.; Natarajan, R.; Patti, M.-E.; Sallari, R.; Sander, M.; Susztak, K. Epigenetics and
Epigenomics: Implications for Diabetes and Obesity. Diabetes 2018, 67, 1923–1931. [CrossRef] [PubMed]
5. Public Health England. 3.8 Million People in England Now Have Diabetes. 2016. Available online:
https://www.gov.uk/government/news/38-million-people-in-england-now-have-diabetes (accessed on 1
September 2019).
6. National Health Service (NHS) Digital and Healthcare Quality Improvement Partnership. National Diabetes
Audit, 2015–2016 Report 1: Care Processes and Treatment Targets. 2017. Available online: http://www.
content.digital.nhs.uk/catalogue/PUB23241/nati-diab-rep1-audi-2015-16.pdf (accessed on 1 September 2019).
7. National Institute for Health and Care Excellence (NICE). Type 2 Diabetes in Adults: Management. 2015.
Available online: Nice.org.uk/guidance/ng28 (accessed on 1 September 2019).
8. World Health Organization. Global Report on Diabetes. 2016. Available online: https://www.who.int/
diabetes/publications/grd-2016/en/ (accessed on 1 September 2019).
9. Hallberg, S.J.; Gershuni, V.M.; Hazbun, T.L.; Athinarayanan, S.J. Reversing Type 2 Diabetes: A Narrative
Review of the Evidence. Nutrients 2019, 11, 766. [CrossRef] [PubMed]
10. Almusaylim, K.; Minett, M.; Binkley, T.L.; Beare, T.M.; Specker, B. Cross-Sectional and Longitudinal
Association between Glycemic Status and Body Composition in Men: A Population-Based Study. Nutrients
2018, 10, 1878. [CrossRef]
11. Muñoz-Garach, A.; García-Fontana, B.; Muñoz-Torres, M. Vitamin D Status, Calcium Intake and Risk of
Developing Type 2 Diabetes: An Unresolved Issue. Nutrients 2019, 11, 642. [CrossRef]
Nutrients 2019, 11, 2177 6 of 6

12. Contreras-Manzano, A.; Villalpando, S.; García-Díaz, C.; Flores-Aldana, M. Cardiovascular Risk Factors and
Their Association with Vitamin D Deficiency in Mexican Women of Reproductive Age. Nutrients 2019, 11,
1211. [CrossRef] [PubMed]
13. Fernández-Cao, J.C.; Warthon-Medina, M.; Moran, V.H.; Arija, V.; Doepking, C.; Serra-Majem, L.; Lowe, N.M.
Zinc Intake and Status and Risk of Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.
Nutrients 2019, 11, 1027. [CrossRef]
14. Brandão-Lima, P.N.; Carvalho, G.B.; Santos, R.K.F.; Santos, B.D.C.; Dias-Vasconcelos, N.L.; Rocha, V.D.S.;
Barbosa, K.B.F.; Pires, L.V. Intakes of Zinc, Potassium, Calcium, and Magnesium of Individuals with Type 2
Diabetes Mellitus and the Relationship with Glycemic Control. Nutrients 2018, 10, 1948. [CrossRef]
15. Song, S.; Lee, J.E. Dietary Patterns Related to Triglyceride and High-Density Lipoprotein Cholesterol and the
Incidence of Type 2 Diabetes in Korean Men and Women. Nutrients 2019, 11, 8. [CrossRef] [PubMed]
16. Hou, Y.-Y.; Ojo, O.; Wang, L.-L.; Wang, Q.; Jiang, Q.; Shao, X.-Y.; Wang, X.-H. A Randomized Controlled Trial
to Compare the Effect of Peanuts and Almonds on the Cardio-Metabolic and Inflammatory Parameters in
Patients with Type 2 Diabetes Mellitus. Nutrients 2018, 10, 1565. [CrossRef] [PubMed]
17. Yamada, S.; Kabeya, Y.; Noto, H. Dietary Approaches for Japanese Patients with Diabetes: A Systematic
Review. Nutrients 2018, 10, 1080. [CrossRef] [PubMed]
18. Burch, E.; Williams, L.T.; Makepeace, H.; Alston-Knox, C.; Ball, L. How Does Diet Change with A Diagnosis
of Diabetes? Protocol of the 3D Longitudinal Study. Nutrients 2019, 11, 158. [CrossRef] [PubMed]
19. Coppell, K.J.; Kataoka, M.; Williams, S.M.; Chisholm, A.W.; Vorgers, S.M.; Mann, J.I. Nutritional intervention
in patients with type 2 diabetes who are hyperglycaemic despite optimised drug treatment—Lifestyle Over
and Above Drugs in Diabetes (LOADD) study: Randomised controlled trial. BMJ 2010, 341, c3337. [CrossRef]
[PubMed]
20. Leech, R.M.; Worsley, A.; Timperio, A.; McNaughton, S.A. Understanding meal patterns: Definitions,
methodology and impact on nutrient intake and diet quality. Nutr. Res. Rev. 2015, 28, 1–21. [CrossRef]
[PubMed]
21. Telle-Hansen, V.H.; Gaundal, L.; Myhrstad, M.C. Polyunsaturated Fatty Acids and Glycemic Control in
Type 2 Diabetes. Nutrients 2019, 11, 1067. [CrossRef]
22. Ojo, O.; Ojo, O.O.; Adebowale, F.; Wang, X.-H. The Effect of Dietary Glycaemic Index on Glycaemia in
Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Nutrients 2018, 10, 373. [CrossRef]
23. Ojo, O.; Ojo, O.O.; Wang, X.-H.; Adegboye, A.R.A. The Effects of a Low GI Diet on Cardiometabolic and
Inflammatory Parameters in Patients with Type 2 and Gestational Diabetes: A Systematic Review and
Meta-Analysis of Randomised Controlled Trials. Nutrients 2019, 11, 1584. [CrossRef]
24. Krzymien, J.; Ladyzynski, P. Insulin in Type 1 and Type 2 Diabetes—Should the Dose of Insulin Before a Meal
be Based on Glycemia or Meal Content? Nutrients 2019, 11, 607. [CrossRef]
25. Tse, L.-S.; Liao, P.-L.; Tsai, C.-H.; Li, C.-H.; Liao, J.-W.; Kang, J.-J.; Cheng, Y.-W. Glycemia Lowering Effect
of an Aqueous Extract of Hedychium coronarium Leaves in Diabetic Rodent Models. Nutrients 2019, 11, 629.
[CrossRef] [PubMed]
26. Vlavcheski, F.; Tsiani, E. Attenuation of Free Fatty Acid-Induced Muscle Insulin Resistance by Rosemary
Extract. Nutrients 2018, 10, 1623. [CrossRef] [PubMed]
27. Huang, Y.-C.; Wu, B.-H.; Chu, Y.-L.; Chang, W.-C.; Wu, M.-C. Effects of Tempeh Fermentation with Lactobacillus
plantarum and Rhizopus oligosporus on Streptozotocin-Induced Type II Diabetes Mellitus in Rats. Nutrients
2018, 10, 1143. [CrossRef] [PubMed]
28. Yang, H.J.; Kim, M.J.; Kwon, D.Y.; Kim, D.S.; Zhang, T.; Ha, C.; Park, S. Combination of Aronia, Red Ginseng,
Shiitake Mushroom and Nattokinase Potentiated Insulin Secretion and Reduced Insulin Resistance with
Improving Gut Microbiome Dysbiosis in Insulin Deficient Type 2 Diabetic Rats. Nutrients 2018, 10, 948.
[CrossRef] [PubMed]

© 2019 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).